13,232 results on '"MOTOR NEURON DISEASE"'
Search Results
52. Neurodegenerative Diseases Progression Markers (MARKERS-NDD) (MARKERS-NDD)
53. Quantitative and Repetitive TMS in ALS - Recruiting for Stage 2 (QuARTS-ALS)
54. Rapamycin Treatment for ALS (RAP-ALS)
55. To Determine the Maximum Tolerated Dose (MTD) of HK-001 in Healthy Volunteers
56. Genetic Study of Familial and Sporadic ALS/Motor Neuron Disease, Miyoshi Myopathy and Other Neuromuscular Disorders
57. Nebulized RNS60 for the Treatment of Amyotrophic Lateral Sclerosis
58. Clinical, Molecular and Imaging Biomarkers in Spinal and Bulbar Muscular Atrophy (SBMA)
59. Electrical Impedance Myography: Natural History Studies inNeuromuscular Disorders and Healthy Volunteers
60. FUSION: A Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of ION363 in Amyotrophic Lateral Sclerosis Participants With Fused in Sarcoma Mutations (FUS-ALS)
61. A Phase 1 Study to Investigate the Safety and Pharmacokinetics of Fosigotifator in Patients With Amyotrophic Lateral Sclerosis
62. First in Human (FIH) Study of ALN-SOD in Adult Participants With Amyotrophic Lateral Sclerosis Associated With Mutation in the SOD1 Gene (SOD1-ALS)
63. A Study to Assess the Safety, Tolerability, and Effect on Disease Progression of BIIB105 in Participants With Amyotrophic Lateral Sclerosis (ALS) and Participants With the ALS Ataxin-2 (ATXN2) Genetic Mutation (ALSpire)
64. Technical and Clinical Validation of the WPM-SEMG Prototype
65. Quality of Life Evaluation with the SRI Questionnaire of ALS Patient with Non-invasive Ventilation (Quality EvALS)
66. Study to Investigate the Efficacy and Safety of FAB122 (Daily Oral Edaravone) in Patients With Amyotrophic Lateral Sclerosis (ADORE)
67. Identifying dysregulated regions in amyotrophic lateral sclerosis through chromatin accessibility outliers
68. Quest to Analyze One Thousand Humans Meditating (QUANTUM)
69. Transcutaneous Electrical Stimulation for Spasticity in Patients With Primary Lateral Sclerosis
70. NYSCF Scientific Discovery Biobank
71. Study of ANX005 in Adults With Amyotrophic Lateral Sclerosis (ALS)
72. Safety Extension Study of Oral Edaravone Administered in Subjects With Amyotrophic Lateral Sclerosis (ALS)
73. Fecal Microbiota Transplantation Effect on Amyotrophic Lateral Sclerosis Patients (FETR-ALS)
74. Clinical Procedures to Support Research in ALS (CAPTURE-ALS)
75. MRG-001 in Patients With Amyotrophic Lateral Sclerosis
76. Yogic Breathing Exercise for People With Amyotrophic Lateral Sclerosis
77. Emotion Processing Among Patients With ALS
78. Clinical Characteristics, Natural History, Health Care Measures, and Genetic Screening in Patients With ALS (ID-ALS)
79. Registry Study of Assistive Devices, Medicines and Healthcare Measures in ALS, SMA and Other Neurological Diseases.
80. AIM's Writing for Healing: A Workshop for Individuals Living With Paralysis
81. Study of Safety, Tolerability, and Biological Activity of LAM-002A in C9ORF72-Associated Amyotrophic Lateral Sclerosis
82. Human Amniotic Mesenchymal Cell Secretome for Neurodegeneration and Neuroinflammation (CONTRASTOME)
83. An IIT Clinical Study to Evaluate the Safety and Efficacy of a Single Intrathecal Injection of RJK002 in Patients With Amyotrophic Lateral Sclerosis (ALS)
84. Evaluate the Safety and Efficacy of Intrathecal Injection of RJK002 in Patients With Amyotrophic Lateral Sclerosis
85. A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RAG-17 in Subjects With Amyotrophic Lateral Sclerosis (ALS) With Superoxide Dismutase Type 1 (SOD1) Gene Mutation
86. Studies in Amyotrophic Lateral Sclerosis (ALS) and Other Neurodegenerative Motor Neuron Disorders
87. A Study of Ranolazine in ALS
88. FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases
89. A Study to Evaluate the Safety, Efficacy, and Pharmacodynamics of PLL001 in ALS Patients
90. Early Feasibility Study of the MyoRegulator® for Treatment of ALS (ALSEFS)
91. Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02) (BG-Speech-02)
92. Phase III Trial of AMX0035 for Amyotrophic Lateral Sclerosis Treatment (Phoenix)
93. A Study of TCD601 (Siplizumab) in Newly Diagnosed Adult Amyotrophic Lateral Sclerosis (ALS) Patients (AURORA)
94. Home-based Remote Digital Monitoring to Assess ALS Progression (Track ALS)
95. ALS/MND Natural History Study Data Repository
96. Reinnervation and Neuromuscular Transmission in ALS (RANTAL)
97. Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-01)
98. Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers
99. HEALEY ALS Platform Trial - Regimen E SLS-005 - Trehalose
100. Gait Patterns in Dual-task Conditions in Patients With Amyotrophic Lateral Sclerosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.